On November 13, 2023, Verve Therapeutics shared positive early Phase I results from the first in vivo base editing human trial, demonstrating “Dose-Dependent Reductions in LDL-C and Blood […]
Self-amplifying mRNA
San Diego-based startup company, Replicate Bioscience, announced on Tuesday, September 12, 2023, that it had begun its first clinical trial on an experimental rabies vaccine using self-amplifying mRNA […]
CAR-T + mRNA for Cancer Therapy
On Monday, August 21, 2023, the Chinese biotech company CARsgen Therapeutics announced that it will enter a collaboration with the mRNA giant Moderna to combine their solid tumor […]
ADARx Pharmaceuticals
The San Diego biotech company, ADARx Pharmaceuticals, announced a successful Series C $200 million round led by Bain Capital Life Sciences and The Column Group Crossover (TCGX) on […]
Alnylam vs. DTx Pharma
On July 17, 2023, DTx Pharma, a preclinical-stage biotech company, announced that it has been acquired by Novartis. It has a platform called “Fatty Acid Ligand Conjugated OligoNucleotide […]
Eleven Therapeutics
On July 17, 2023, Novo Nordisk announced that it would enter into a collaboration with a startup company founded in 2020, Eleven Therapeutics, to “identify new medicines that […]
Continuous mRNA Manufacturing
News came out on July 13, 2023, that the “FDA backs new $82M mRNA manufacturing center at MIT” to build a continuous mRNA manufacturing platform. To me, who […]